디에이치엑스컴퍼니 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 프라임코어, was filed 15 Apr 2026.
디에이치엑스컴퍼니: what insiders have been doing
디에이치엑스컴퍼니 is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 2 November 2025 to 2 November 2026, the disclosure feed for 디에이치엑스컴퍼니 logged 9 filings by 3 insiders.
The flow runs one way only: 2 insiders bought (4 purchases totalling €2.3M) and nobody sold on the market. The amount is not disclosed for 3 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The largest single trade was a purchase of €2.3M by 프라임코어, published on 15 April 2026.
The last insider purchase was made public on 15 April 2026, 209 days ago. Typically, a trade is published a median of 7 days after it takes place. This delay matters because a trade only becomes useful information once it is public.
With 9 filings in twelve months, the company is more active than the median of 7 filings across the 2,655 companies we follow on the same exchange. Our records for 디에이치엑스컴퍼니 go back to 2021, with 5 purchases and 17 sales on the open market in total.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +0.0%Entry ₩693 · Close at T+90 ₩693
- +102.0%Entry ₩343 · Close at T+90 ₩693
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 8,020,000 shares@ ₩500.00100.0% of flowShareKRXDART:20260415000596Canonical exit: 7 Jul 2026 (T+90)
- 8,020,000 sharesKRXDART:20260415000593Canonical exit: 7 Jul 2026 (T+90)
- ●Executives0DART
- 2,145,665 sharesKRXDART:20260130000566Canonical exit: 23 Apr 2026 (T+90)
- 2,145,665 sharesShareKRXDART:20260130000570Canonical exit: 30 Apr 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 7,803,738 sharesKRXDART:20250708000206Canonical exit: 29 Sept 2025 (T+90)
- ●Executives0DART
- 12,435,425 sharesKRXDART:20250124000799
- 12,435,425 sharesShareKRXDART:20250124000803
- ●Executives0DART
- ●Executives0DART
- 4,044,607 sharesKRXDART:20240110000862
- 12,435,425 sharesKRXDART:20231211000333
- 12,435,425 sharesKRXDART:20231117000302
- ShareKRXDART:20230918000345
- 12,435,425 sharesKRXDART:20230918000343
- 12,435,425 sharesKRXDART:20230918000340
- 12,435,425 sharesKRXDART:20230816000237
- ●Executives0DART
- ●Executives0DART
25 of 47 declarations
About 디에이치엑스컴퍼니
디에이치엑스컴퍼니 is a company operating in the health and pharmaceutical sector. It is listed on the XKRX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations